These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.
3. [Drawing up guidelines for the attendance of physical health of patients with severe mental illness]. Saravane D; Feve B; Frances Y; Corruble E; Lancon C; Chanson P; Maison P; Terra JL; Azorin JM; Encephale; 2009 Sep; 35(4):330-9. PubMed ID: 19748369 [TBL] [Abstract][Full Text] [Related]
5. TAILOR - tapered discontinuation versus maintenance therapy of antipsychotic medication in patients with newly diagnosed schizophrenia or persistent delusional disorder in remission of psychotic symptoms: study protocol for a randomized clinical trial. Stürup AE; Jensen HD; Dolmer S; Birk M; Albert N; Nielsen M; Hjorthøj C; Eplov L; Ebdrup BH; Mors O; Nordentoft M Trials; 2017 Sep; 18(1):445. PubMed ID: 28962668 [TBL] [Abstract][Full Text] [Related]
6. [Cost-effectiveness analysis of schizophrenic patient care settings: impact of an atypical antipsychotic under long-acting injection formulation]. Llorca PM; Miadi-Fargier H; Lançon C; Jasso Mosqueda G; Casadebaig F; Philippe A; Guillon P; Mehnert A; Omnès LF; Chicoye A; Durand-Zaleski I Encephale; 2005; 31(2):235-46. PubMed ID: 15959450 [TBL] [Abstract][Full Text] [Related]
7. The expert consensus guideline series. Optimizing pharmacologic treatment of psychotic disorders. Introduction: methods, commentary, and summary. Kane JM; Leucht S; Carpenter D; Docherty JP; J Clin Psychiatry; 2003; 64 Suppl 12():5-19. PubMed ID: 14640142 [TBL] [Abstract][Full Text] [Related]
8. Antipsychotic treatment for late-life schizophrenia. Sable JA; Jeste DV Curr Psychiatry Rep; 2002 Aug; 4(4):299-306. PubMed ID: 12126599 [TBL] [Abstract][Full Text] [Related]
9. Long-acting atypical antipsychotics in schizophrenia: A systematic review and meta-analyses of effects on functional outcome. Olagunju AT; Clark SR; Baune BT Aust N Z J Psychiatry; 2019 Jun; 53(6):509-527. PubMed ID: 30957510 [TBL] [Abstract][Full Text] [Related]
10. Long-acting injectable antipsychotics in the elderly: guidelines for effective use. Masand PS; Gupta S Drugs Aging; 2003; 20(15):1099-110. PubMed ID: 14651433 [TBL] [Abstract][Full Text] [Related]
11. Psychosocial interventions for people with schizophrenia or psychosis on minimal or no antipsychotic medication: A systematic review. Cooper RE; Laxhman N; Crellin N; Moncrieff J; Priebe S Schizophr Res; 2020 Nov; 225():15-30. PubMed ID: 31126806 [TBL] [Abstract][Full Text] [Related]
12. Beyond Clinical Remission in First Episode Psychosis: Thoughts on Antipsychotic Maintenance vs. Guided Discontinuation in the Functional Recovery Era. Alvarez-Jimenez M; O'Donoghue B; Thompson A; Gleeson JF; Bendall S; Gonzalez-Blanch C; Killackey E; Wunderink L; McGorry PD CNS Drugs; 2016 May; 30(5):357-68. PubMed ID: 27106296 [TBL] [Abstract][Full Text] [Related]
13. Antipsychotic medication versus psychological intervention versus a combination of both in adolescents with first-episode psychosis (MAPS): a multicentre, three-arm, randomised controlled pilot and feasibility study. Morrison AP; Pyle M; Maughan D; Johns L; Freeman D; Broome MR; Husain N; Fowler D; Hudson J; MacLennan G; Norrie J; Shiers D; Hollis C; James A; Lancet Psychiatry; 2020 Sep; 7(9):788-800. PubMed ID: 32649925 [TBL] [Abstract][Full Text] [Related]
14. Summary of the comparative effectiveness review on off-label use of atypical antipsychotics. Maher AR; Theodore G J Manag Care Pharm; 2012 Jun; 18(5 Suppl B):S1-20. PubMed ID: 22784311 [TBL] [Abstract][Full Text] [Related]